NAMPT and metabolic dysfunction-associated steatotic liver disease: IHC for NAMPT expression in STZ/HFD-induced NAFLD livers showed significantly elevated intensity of NAMPT immunostaining compared to the mild NAMPT immunostaining in control livers (Figure 3A), findings verified by liver staining quantification (n = 16, p < .05) (Figure 3B).